APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endorphins

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Endorphins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025185 pages

Choose your research edition.

Industry ResearchEndorphins Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Endorphins Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Endorphins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endorphins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Endorphins Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Endorphins market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endorphins include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endorphins market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endorphins and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endorphins sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endorphins market size, projected growth trends, production technologies, key applications, and end-use industries.

Endorphins Segment by Company

Assertio Therapeutics Inc.

Cipher Pharmaceuticals Inc.

Egalet Corp.

Endo International Plc

Lannett Co. Inc.

Pfizer

Johnson & Johnson

Endorphins Segment by Type

Sigma-Endorphins

Gamma-Endorphins

Beta-Endorphins

Alpha-Endorphins

Endorphins Segment by Application

Institutional Pharmacies

Retail Pharmacies

Online Pharmacies

Endorphins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endorphins market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Endorphins Industry Trends Table 2. Endorphins Industry Drivers Table 3. Endorphins Industry Opportunities and Challenges Table 4. Endorphins Industry Restraints Table 5. Global Endorphins Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Endorphins Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Endorphins Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Endorphins Sales Market Share by Manufacturers Table 9. Global Endorphins Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Endorphins Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Endorphins Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Endorphins Manufacturers, Product Type & Application Table 13. Global Endorphins Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Endorphins by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sigma-Endorphins Table 17. Major Manufacturers of Gamma-Endorphins Table 18. Major Manufacturers of Beta-Endorphins Table 19. Major Manufacturers of Alpha-Endorphins Table 20. Global Endorphins Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Endorphins Sales by Type (2021-2026) & (K Units) Table 22. Global Endorphins Sales by Type (2027-2032) & (K Units) Table 23. Global Endorphins Sales Market Share by Type (2021-2026) Table 24. Global Endorphins Sales Market Share by Type (2027-2032) Table 25. Global Endorphins Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Endorphins Revenue by Type (2021-2026) & (K Units) Table 27. Global Endorphins Revenue by Type (2027-2032) & (K Units) Table 28. Global Endorphins Revenue Market Share by Type (2021-2026) Table 29. Global Endorphins Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Institutional Pharmacies Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Global Endorphins Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Endorphins Sales by Application (2021-2026) & (K Units) Table 35. Global Endorphins Sales by Application (2027-2032) & (K Units) Table 36. Global Endorphins Sales Market Share by Application (2021-2026) Table 37. Global Endorphins Sales Market Share by Application (2027-2032) Table 38. Global Endorphins Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Endorphins Revenue by Application (2021-2026) & (K Units) Table 40. Global Endorphins Revenue by Application (2027-2032) & (K Units) Table 41. Global Endorphins Revenue Market Share by Application (2021-2026) Table 42. Global Endorphins Revenue Market Share by Application (2027-2032) Table 43. Global Endorphins Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Endorphins Sales by Region (2021-2026) & (K Units) Table 45. Global Endorphins Sales Market Share by Region (2021-2026) Table 46. Global Endorphins Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Endorphins Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Endorphins Sales by Country (2021-2026) & (K Units) Table 50. North America Endorphins Sales by Country (2027-2032) & (K Units) Table 51. Europe Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Endorphins Sales by Country (2021-2026) & (K Units) Table 53. Europe Endorphins Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Endorphins Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Endorphins Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Endorphins Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Endorphins Sales by Country (2027-2032) & (K Units) Table 60. Global Endorphins Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Endorphins Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Endorphins Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Endorphins Revenue Market Share by Region (2021-2026) Table 64. Global Endorphins Revenue Market Share by Region (2027-2032) Table 65. Assertio Therapeutics Inc. Company Information Table 66. Assertio Therapeutics Inc. Business Overview Table 67. Assertio Therapeutics Inc. Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Assertio Therapeutics Inc. Endorphins Product Portfolio Table 69. Assertio Therapeutics Inc. Recent Development Table 70. Cipher Pharmaceuticals Inc. Company Information Table 71. Cipher Pharmaceuticals Inc. Business Overview Table 72. Cipher Pharmaceuticals Inc. Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cipher Pharmaceuticals Inc. Endorphins Product Portfolio Table 74. Cipher Pharmaceuticals Inc. Recent Development Table 75. Egalet Corp. Company Information Table 76. Egalet Corp. Business Overview Table 77. Egalet Corp. Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Egalet Corp. Endorphins Product Portfolio Table 79. Egalet Corp. Recent Development Table 80. Endo International Plc Company Information Table 81. Endo International Plc Business Overview Table 82. Endo International Plc Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Endo International Plc Endorphins Product Portfolio Table 84. Endo International Plc Recent Development Table 85. Lannett Co. Inc. Company Information Table 86. Lannett Co. Inc. Business Overview Table 87. Lannett Co. Inc. Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lannett Co. Inc. Endorphins Product Portfolio Table 89. Lannett Co. Inc. Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pfizer Endorphins Product Portfolio Table 94. Pfizer Recent Development Table 95. Johnson & Johnson Company Information Table 96. Johnson & Johnson Business Overview Table 97. Johnson & Johnson Endorphins Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Johnson & Johnson Endorphins Product Portfolio Table 99. Johnson & Johnson Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Endorphins Distributors List Table 103. Endorphins Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Endorphins Product Image Figure 2. Global Endorphins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endorphins Market Size (2021-2032) & (US$ Million) Figure 4. Global Endorphins Sales (2021-2032) & (K Units) Figure 5. Global Endorphins Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Endorphins Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sigma-Endorphins Image Figure 9. Gamma-Endorphins Image Figure 10. Beta-Endorphins Image Figure 11. Alpha-Endorphins Image Figure 12. Global Endorphins Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Endorphins Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Endorphins Sales Market Share by Type (2021-2032) Figure 15. Global Endorphins Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Endorphins Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Endorphins Revenue Market Share by Type (2021-2032) Figure 18. Institutional Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Global Endorphins Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Endorphins Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Endorphins Sales Market Share by Application (2021-2032) Figure 24. Global Endorphins Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Endorphins Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Endorphins Revenue Market Share by Application (2021-2032) Figure 27. North America Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Endorphins Sales Market Share by Country (2021-2032) Figure 29. U.S. Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Endorphins Sales Market Share by Country (2021-2032) Figure 34. Germany Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Endorphins Sales Market Share by Country (2021-2032) Figure 41. China Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Endorphins Sales Market Share by Country (2021-2032) Figure 49. Brazil Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Endorphins Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Endorphins Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Endorphins Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Endorphins Revenue (2021-2032) & (US$ Million) Figure 60. North America Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Endorphins Revenue (2021-2032) & (US$ Million) Figure 62. Europe Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Endorphins Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Endorphins Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Endorphins Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Endorphins Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sigma-Endorphins
  • Gamma-Endorphins
  • Beta-Endorphins
  • Alpha-Endorphins
Applications
  • Institutional Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Assertio Therapeutics Inc.
  • Cipher Pharmaceuticals Inc.
  • Egalet Corp.
  • Endo International Plc
  • Lannett Co. Inc.
  • Pfizer
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Endorphins Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Endorphins Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Endorphins Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Endorphins Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Endorphins Market Dynamics
  1. 2.1 Endorphins Industry Trends
  2. 2.2 Endorphins Industry Drivers
  3. 2.3 Endorphins Industry Opportunities and Challenges
  4. 2.4 Endorphins Industry Restraints
3 Endorphins Market by Manufacturers
  1. 3.1 Global Endorphins Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Endorphins Sales by Manufacturers (2021-2026)
  3. 3.3 Global Endorphins Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Endorphins Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endorphins Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Endorphins Manufacturers, Product Type & Application
  7. 3.7 Global Endorphins Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endorphins Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endorphins Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endorphins Tier 1, Tier 2, and Tier 3
4 Endorphins Market by Type
  1. 4.1 Endorphins Type Introduction
  2. 4.1.1 Sigma-Endorphins
  3. 4.1.2 Gamma-Endorphins
  4. 4.1.3 Beta-Endorphins
  5. 4.1.4 Alpha-Endorphins
  6. 4.2 Global Endorphins Sales by Type
  7. 4.2.1 Global Endorphins Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Endorphins Sales by Type (2021-2032)
  9. 4.2.3 Global Endorphins Sales Market Share by Type (2021-2032)
  10. 4.3 Global Endorphins Revenue by Type
  11. 4.3.1 Global Endorphins Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Endorphins Revenue by Type (2021-2032)
  13. 4.3.3 Global Endorphins Revenue Market Share by Type (2021-2032)
5 Endorphins Market by Application
  1. 5.1 Endorphins Application Introduction
  2. 5.1.1 Institutional Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Endorphins Sales by Application
  6. 5.2.1 Global Endorphins Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endorphins Sales by Application (2021-2032)
  8. 5.2.3 Global Endorphins Sales Market Share by Application (2021-2032)
  9. 5.3 Global Endorphins Revenue by Application
  10. 5.3.1 Global Endorphins Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Endorphins Revenue by Application (2021-2032)
  12. 5.3.3 Global Endorphins Revenue Market Share by Application (2021-2032)
6 Global Endorphins Sales by Region
  1. 6.1 Global Endorphins Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endorphins Sales by Region (2021-2032)
  3. 6.2.1 Global Endorphins Sales by Region (2021-2026)
  4. 6.2.2 Global Endorphins Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Endorphins Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Endorphins Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Endorphins Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Endorphins Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Endorphins Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Endorphins Revenue by Region
  1. 7.1 Global Endorphins Revenue by Region
  2. 7.1.1 Global Endorphins Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Endorphins Revenue by Region (2021-2026)
  4. 7.1.3 Global Endorphins Revenue by Region (2027-2032)
  5. 7.1.4 Global Endorphins Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Endorphins Revenue (2021-2032)
  8. 7.2.2 North America Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Endorphins Revenue (2021-2032)
  11. 7.3.2 Europe Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Endorphins Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Endorphins Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Endorphins Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Assertio Therapeutics Inc.
  2. 8.1.1 Assertio Therapeutics Inc. Company Information
  3. 8.1.2 Assertio Therapeutics Inc. Business Overview
  4. 8.1.3 Assertio Therapeutics Inc. Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
  6. 8.1.5 Assertio Therapeutics Inc. Recent Developments
  7. 8.2 Cipher Pharmaceuticals Inc.
  8. 8.2.1 Cipher Pharmaceuticals Inc. Company Information
  9. 8.2.2 Cipher Pharmaceuticals Inc. Business Overview
  10. 8.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
  12. 8.2.5 Cipher Pharmaceuticals Inc. Recent Developments
  13. 8.3 Egalet Corp.
  14. 8.3.1 Egalet Corp. Company Information
  15. 8.3.2 Egalet Corp. Business Overview
  16. 8.3.3 Egalet Corp. Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Egalet Corp. Endorphins Product Portfolio
  18. 8.3.5 Egalet Corp. Recent Developments
  19. 8.4 Endo International Plc
  20. 8.4.1 Endo International Plc Company Information
  21. 8.4.2 Endo International Plc Business Overview
  22. 8.4.3 Endo International Plc Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Endo International Plc Endorphins Product Portfolio
  24. 8.4.5 Endo International Plc Recent Developments
  25. 8.5 Lannett Co. Inc.
  26. 8.5.1 Lannett Co. Inc. Company Information
  27. 8.5.2 Lannett Co. Inc. Business Overview
  28. 8.5.3 Lannett Co. Inc. Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lannett Co. Inc. Endorphins Product Portfolio
  30. 8.5.5 Lannett Co. Inc. Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Endorphins Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Johnson & Johnson
  38. 8.7.1 Johnson & Johnson Company Information
  39. 8.7.2 Johnson & Johnson Business Overview
  40. 8.7.3 Johnson & Johnson Endorphins Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Johnson & Johnson Endorphins Product Portfolio
  42. 8.7.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endorphins Value Chain Analysis
  2. 9.1.1 Endorphins Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endorphins Production Mode & Process
  6. 9.2 Endorphins Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endorphins Distributors
  9. 9.2.3 Endorphins Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst